Hims & Hers Health (HIMS) EBT Margin (2020 - 2026)
Hims & Hers Health (HIMS) posted EBT Margin of 16.7% for Q1 2026, down 662.16% sequentially from 2.97% in Q4 2025, and down 2702.0% YoY from 0.64% in Q1 2025.
Hims & Hers Health (HIMS) EBT Margin (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported EBT Margin for 7 years, with the latest figure at 16.7% in Q1 2026.
- Quarterly EBT Margin fell 2702.0% year-over-year to 16.7% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.61% (down 832.0% YoY) and the FY2025 annual result came in at 5.28%, up 42.0% from the prior year.
- EBT Margin slipped to 16.7% in Q1 2026 per HIMS's latest filing, from 2.97% in the prior quarter.
- Over five years, EBT Margin peaked at 10.32% in Q1 2025 and troughed at 17.32% in Q2 2022.
- A 5-year average of 2.33% and a median of 0.89% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2026: EBT Margin surged 8214 bps in 2022, then plunged 2702 bps in 2026.
- Over 5 years, EBT Margin stood at 6.6% in 2022, then jumped by 114 bps to 0.89% in 2023, then soared by 420 bps to 4.63% in 2024, then sank by 36 bps to 2.97% in 2025, then sank by 662 bps to 16.7% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 16.7%, 2.97%, and 2.04% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | -12.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.30% |
| Mar 31, 2026 | -16.70% |
| Dec 31, 2025 | 2.97% |
| Sep 30, 2025 | 2.04% |
| Jun 30, 2025 | 6.03% |
| Mar 31, 2025 | 10.32% |
| Dec 31, 2024 | 4.63% |
| Sep 30, 2024 | 5.88% |
| Jun 30, 2024 | 4.25% |
| Mar 31, 2024 | 4.46% |
| Dec 31, 2023 | 0.89% |
| Sep 30, 2023 | -3.05% |
| Jun 30, 2023 | -3.45% |
| Mar 31, 2023 | -5.07% |
| Dec 31, 2022 | -6.60% |
| Sep 30, 2022 | -13.02% |
| Jun 30, 2022 | -17.32% |
| Mar 31, 2022 | -15.95% |
| Dec 31, 2021 | -36.89% |
| Sep 30, 2021 | -25.77% |